Histone modifications and cancer

JE Audia, RM Campbell - Cold Spring Harbor …, 2016 - cshperspectives.cshlp.org
Histone posttranslational modifications represent a versatile set of epigenetic marks
involved not only in dynamic cellular processes, such as transcription and DNA repair, but …

Inhibitors of protein methyltransferases and demethylases

HU Kaniskan, ML Martini, J Jin - Chemical reviews, 2018 - ACS Publications
Post-translational modifications of histones by protein methyltransferases (PMTs) and
histone demethylases (KDMs) play an important role in the regulation of gene expression …

Critical roles of non-histone protein lysine methylation in human tumorigenesis

R Hamamoto, V Saloura, Y Nakamura - Nature Reviews Cancer, 2015 - nature.com
Several protein lysine methyltransferases and demethylases have been identified to have
critical roles in histone modification. A large body of evidence has indicated that their …

The emerging role of KDM5A in human cancer

GJ Yang, MH Zhu, XJ Lu, YJ Liu, JF Lu… - Journal of hematology & …, 2021 - Springer
Histone methylation is a key posttranslational modification of chromatin, and its
dysregulation affects a wide array of nuclear activities including the maintenance of genome …

A potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases

MS Eram, Y Shen, MM Szewczyk, H Wu… - ACS chemical …, 2016 - ACS Publications
Protein arginine methyltransferases (PRMTs) play a crucial role in a variety of biological
processes. Overexpression of PRMTs has been implicated in various human diseases …

Diagnostic and prognostic epigenetic biomarkers in cancer

P Costa-Pinheiro, D Montezuma, R Henrique… - …, 2015 - Taylor & Francis
Growing cancer incidence and mortality worldwide demands development of accurate
biomarkers to perfect detection, diagnosis, prognostication and monitoring. Urologic …

Therapeutic m6A Eraser ALKBH5 mRNA-Loaded Exosome–Liposome Hybrid Nanoparticles Inhibit Progression of Colorectal Cancer in Preclinical Tumor Models

S Wu, J Yun, W Tang, G Familiari, M Relucenti, J Wu… - ACS …, 2023 - ACS Publications
Although therapeutic targets have been developed for colorectal cancer (CRC) therapy, the
therapeutic effects are not ideal and the survival rate for CRC patients remains poor …

JMJD family proteins in cancer and inflammation

W Manni, X Jianxin, H Weiqi, C Siyuan… - Signal transduction and …, 2022 - nature.com
The occurrence of cancer entails a series of genetic mutations that favor uncontrollable
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …

Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression

C Du, C Lv, Y Feng, S Yu - Journal of Experimental & Clinical Cancer …, 2020 - Springer
Background Accumulating evidence supports that lysine-specific demethylase 5 (KDM5)
family members act as oncogenic drivers. This study was performed to elucidate the …

Advances in histone demethylase KDM4 as cancer therapeutic targets

DH Lee, GW Kim, YH Jeon, J Yoo, SW Lee… - The FASEB …, 2020 - Wiley Online Library
Abstract The KDM4 subfamily H3K9 histone demethylases are epigenetic regulators that
control chromatin structure and gene expression by demethylating histone H3K9, H3K36 …